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Dynamic histone acetylation, catalyzed by lysine acetyltransferases and HDACs, is critical to IEG
expression. Expression of IEGs, such as FOSL1, is induced by several signal transduction pathways
resulting in activation of the protein kinase MSK and phosphorylation of histone H3 at serine 10
of nucleosomes (the nucleosome response) at the upstream promoter and regulatory region of tar-
get genes. HDAC inhibitors prevent FOSL1 gene induction and the association of HDAC1, 2 and 3 with
the gene body. However, HDAC inhibitors did not prevent the nucleosome response. Thus HDAC
inhibitors perturb events downstream of the nucleosome response required for FOSL1 transcription
initiation.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction These events contribute to the remodeling of nucleosomes locatedThe nucleosomal response plays a major role in the expression
of immediate early genes (IEGs), such as Fos, Jun, FosL1 and Ptgs2
[1,2]. The nucleosomal response results from the stimulation of
the RAS-mitogen activated protein kinase (MAPK) or stress acti-
vated pathways and the activation of ERK or p38, respectively.
ERK and p38 phosphorylate and activate the mitogen- and stress-
activated protein kinases (MSK) 1 and 2. Once activated, MSK is re-
cruited to regulatory regions of IEGs to phosphorylate histone H3
at S10 or S28. The phosphorylated H3 recruits proteins 14-3-3 e
or f. The events that follow result in the remodeling of nucleo-
somes at the regulatory region, recruitment of transcription factors
and the initiation of transcription [1,3].
Important in transcriptional induction of the IEGs is dynamic his-
tone acetylation [4,5]. Lysine acetyltransferases (KAT) and histone
deacetylases (HDAC) recruited to the regulatory regions of IEGs cat-
alyze dynamic protein acetylation of histones and other proteins.at the regulatory regions. HDAC1 and 2 in association with several
other proteins are present in corepressor complexes Sin3A, NuRD
and CoREST. HDAC3 is in corepressor complexes, SMRT and NCoR,
with otherHDACs such asHDAC4. TheHDAC corepressor complexes
are recruited to regulatory regions by transcription factors andother
DNA-binding proteins. Dynamically acetylated histones are also
associated with the coding regions of transcribed genes [1,6,7] and
have a role in splicing of pre-mRNA [8,9]. In yeast, there is evidence
that recruitment of HDACs to the gene body is mediated by RNA
polymerase II and elongation [10,11].Whether a similarmechanism
is inplay in recruitingHDACs to thecoding regionof IEGs inmamma-
lian cells is currently not known.
Inhibition of HDAC activity impacts the expression of less than
10% of genes, with these genes either being up- or down-regulated.
Further, there is emerging evidence that inhibition of HDACs im-
pacts the splicing of many genes [8,9,12]. Among the genes that
are up-regulated by HDAC inhibitors is CDKN1A (also known as
p21, WAF1, CIP1). However, for induction to take place the mito-
gen- and stress-activated protein kinase (MSK)-induced nucleo-
somal response must be active [13].
In contrast to CDKN1A, the mitogen- or stress-induced expres-
sion of several IEGs is attenuated by the treatment of cells with
HDAC inhibitors before the addition of the mitogen or stress agent
[4]. Whether the nucleosomal response was compromised for
these IEGs by HDAC inhibitors is currently not known.
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Fig. 1. TPA induced increased expression of FOSL1 gene with the accumulation of class I HDACs in gene body region in HCT116 cells. (A) Serum starved HCT116 cells were
treated with 100 nM TPA for 0, 30 or 60 min. Total mRNA was isolated and quantiﬁed by real time PCR. Fold changes of FOSL1mRNA were normalized to cyclophilin E levels
and time 0 values, and are the mean of three independent experiments. The error bars represent standard deviation. (B) Schematic representation of FOSL1 gene showing the
positions of the amplicons used in ChIP assays. Exons are indicated by boxes. Transcription factor binding sites in the regulatory region of the gene are shown in the ampliﬁed
region. EBS, Ets binding site; GC, GC box; TRE, TPA-responsive element; SRE, serum-responsive element; ATF, activating transcription factor. (C) HCT116 cells were serum
deprived and were treated with TPA as indicated in ﬁgure. Cells were double cross-linked with DSP and formaldehyde and ChIP assays were performed with HDAC1, 2 or 3
antibodies. Equal amounts of input and immunoprecipitated DNA were analyzed by real time PCR at the promoter and gene body region (exons 1 and 4) of FOSL1 gene. The
enrichment values are relative to values of time 0, and are the mean of three independent experiments, represented as mean ± standard deviation.
D.H. Khan, J.R. Davie / FEBS Letters 587 (2013) 1510–1517 1511In this study we determined which HDACs are recruited to the
regulatory and coding regions of the induced IEG FOSL1 and the
dependence of HDAC recruitment on transcription. Further we
determined whether HDAC inhibitors altered the nucleosomal re-
sponse required for the induced expression of the FOSL1 gene.
We demonstrate that HDAC1, 2 and 3 are recruited to the regula-
tory and coding regions of the induced FOSL1 gene, with on-going
transcription being required for recruitment of HDAC1, 2 and 3 to
the gene body. HDAC inhibitors did not impact the nucleosomal re-
sponse, but disconnected the nucleosomal response from the
events required for the initiation of transcription.
2. Materials and methods
2.1. Cell culture and treatments
The human colon carcinoma cell line, HCT116 was cultured at
37 C in a humidiﬁed atmosphere containing 5% CO2 in McCoy’s
5A medium (Sigma) supplemented with 10% fetal bovine serum(FBS), 100 units/ml penicillin, 100 lg/ml streptomycin and
250 ng/ml amphotericin B. To induce the RAS-MAPK signaling
pathway, 80–90% conﬂuent cells were serum starved for 48 h
and then treated with a phorbol ester, 12-O-tetradecanoyl-
phorbol-13-acetate (TPA) (100 nM, Sigma) for various time periods
(0, 30, or 60 min). When mentioned, serum starved HCT116 cells
were treated with HDAC inhibitor, trichostatin A (TSA, 250 nM,
Sigma) or apicidin (150 nM, Sigma) for 30 min prior to TPA treat-
ment. In transcriptional inhibition studies, serum starved HCT116
cells were treated with TPA (60 min) or pre-treated with DRB
(5,6,dichlorobenzimidazole riboside, Sigma) (25 lg/ml) or actino-
mycin D (Sigma) (20 lg/ml) for 1hr followed by TPA treatment
for 60 min.
2.2. RNA isolation and real time RT-PCR
Total RNA was isolated from either serum starved HCT116 cells
treated with TPA (0, 30, or 60 min) alone or cells pretreated with
TSA or apicidin for 30 min followed by TPA treatment (0, 30, or
Fig. 2. Transcription dependent recruitment of class I HDACs in the gene body of FOSL1 gene. Serum starved HCT116 cells were treated with 100 nM TPA for 60 min (Control)
or were treated with DRB (25 lg/ml) or actinomycin D (Act-D) (20 lg/ml) for 1 h prior to TPA treatment (60 min). Cells were dual cross-linked, and ChIP assays were done
with HDAC1, 2 or 3 antibodies. Equal amounts of ChIP and input DNAwere used for real time PCR analyses at the upstream promoter and gene body regions of the FOSL1 gene.
Enrichment values of each treatment were relative to input values, and are the average of three independent experiments. The error bars represent standard deviation.
A
B
Fig. 3. Effect of HDAC inhibitors on FOSL1 expression. HCT116 cells cultured under
serum-deprived conditions were treated with 250 nM TSA (A) or with 150 nM
apicidin (B) for 30 min before a time course treatment with 100 nM TPA for 0, 30 or
60 min. Total mRNA was isolated and fold change of FOSL1mRNA was calculated by
normalizing values against cyclophilin E, relative to 0 time values. Fold change
values are the mean of three independent experiments, and error bars indicate
standard deviation.
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turer’s instructions. Total RNA (400 ng) was used for cDNA synthe-
sis using M-MLV reverse transcriptase (Invitrogen). Real-time PCR
reactions were performed on iCycler IQ5 (BioRad). FOSL1 and PTGS2
mRNA levels were normalized against a house keeping gene, Cyclo-
philin E. Fold change was calculated relative to 0 time values.2.3. Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation (ChIP) experiments were done
as previously described [1], with an additional protein–protein
cross-linking step. Cells were incubated with 1.0 mM DSP (dithi-
obis[succinimidylpropionate]) (Thermo Fisher Scientiﬁc) for
30 min at room temperature according to manufacturer’s instruc-
tion, prior to formaldehyde cross-linking. Dual cross-linked chro-
matin was processed to mononucleosomes and chromatin
immunoprecipitations were done with antibodies against HDAC1
(Afﬁnity Bioreagents), HDAC2 (Afﬁnity Bioreagents), HDAC3 (Ab-
cam), acetyl histone-H3 (Millipore), acetyl histone-H4 (Millipore),
RNA polymerase II (RNAPII) (Millipore), RNAPIIS2ph (Abcam),
H3S10ph (Santa Cruz Biotechnology), 14-3-3 e (Santa Cruz Bio-
technology) and 14-3-3 f (Santa Cruz Biotechnology). Equal
amounts of input and ChIP DNA (1.0 ng) were used for real time
PCR on iCycler IQ5 (BioRad). The fold enrichment was calculated
as previously described [1]. The following primers were used:
FOSL1-promoter-F: 50-GTGCTATTTTGTGGGAGCAG-30
FOSL1-promoter-R: 50-TGGTGTAACTTCCTCGCCGC-30
FOSL1-Ex1-F: 50-GCATGTTCCGAGACTTCGGG-30
FOSL1-Ex1-R: 50-TGCTGGGCTGCCTGCGCTGC-30
FOSL1-Ex4-F: 50-CACACCCTCCCTAACTCCTTT-30
FOSL1-Ex4-R: 50-TGCTGCTACTCTTGCGATGA-30
2.4. Preparation of cellular extract, histone isolation and
immunoblotting
Cellular extracts were prepared in IP buffer (50 mM Tris–HCl,
pH 8.0, 150 mM NaCl, 1.0 mM EDTA, 0.5% NP-40) containing phos-
phatase and protease inhibitors (Roche).Total cellular protein
extracts (20 lg) were resolved by 10% SDS–PAGE and immuno-
chemical staining was performed with anti-ERK1/2 (Invitrogen)
and anti-phospho-p44/42 MAPK (ERK1/2) Thr202/Tyr204 (Cell Sig-
naling Technology), anti-p38 MAPK (Cell Signaling Technology),
and, anti phospho-p38 MAPK (Thr180/Tyr182) (Cell Signaling
Technology) antibodies. Acid extraction of histones was done as
described previously [14] and were resolved (5.0 lg of histones)
by 15% SDS–PAGE and stained immunochemically with antibodies
against anti-H3S10ph (Santa Cruz Biotechnology), anti-H3S28ph
(Abcam), and anti-H3 (Millipore).
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Fig. 4. HDAC inhibition with TSA or apicidin attenuates the recruitment of RNA
polymerase II at regulatory region of FOSL1 gene. Serum starved HCT116 cells were
left untreated (A) or treated with 250 nM TSA (B) or 150 nM apicidin (B) for 30 min
prior to TPA stimulation (100 nM) for 0, 30 or 60 min. Dual cross-linked mononu-
cleosomes were prepared and used in ChIP assays with anti-RNAPII and anti-
RNAPIIS5ph antibodies (total and initiation form of RNAPII). Equal amounts of input
and immunoprecipitated DNA were assessed at the upstream promoter region of
FOSL1 gene with real time PCR. Enrichment values are the mean of three
independent experiments, relative to time 0 values, represented as mean ± standard
deviation.
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3.1. Transcription dependent recruitment of class I HDACs to FOSL1
We have previously reported that TPA stimulation of the RAS-
MAPK pathway in mouse ﬁbroblasts results in the induced expres-
sion of the Fosl1 and Ptgs2 genes [1]. TPA treatment of serum
starved human colorectal carcinoma HCT116 cells also resultedin the increased expression of the FOSL1 and PTGS2 genes
(Fig. 1A and Fig. S1A). Histone acetylation turnover is important
for activation of inducible genes [5]. To determine the loading of
class I HDACs along the FOSL1 gene, we applied a dual cross-linking
(DSP followed by formaldehyde) chromatin immunoprecipitation
(ChIP) assay [15]. In response to the TPA-induction of the FOSL1
gene, there was an accumulation of class I HDACs (HDAC1, 2 and
3) at the upstream promoter region and gene body (exons 1 and
4), increasing in parallel with the increased expression of the FOSL1
gene (Fig. 1B and C).
The requirement of on-going transcription in the recruitment of
HDACs to the upstream promoter region and FOSL1 gene body was
determined. Serum starved HCT116 cells were incubated for
60 min with or without the transcription inhibitors, DRB or actino-
mycin D, followed by an incubation with TPA for 60 min to induce
FOSL1 gene expression. The results of the dual cross-linking ChIP
assays show that both transcription inhibitors prevented the
recruitment of class I HDAC to the FOSL1 upstream promoter re-
gion and gene body (Fig. 2). These results suggest that TPA-induced
transcription of the FOSL1 is required to recruit class I HDACs to the
gene.
3.2. HDAC inhibitors attenuate the recruitment of HDACs to the FOSL1
gene body
Previous reports have shown that the HDAC inhibitor, TSA (a
pan HDAC inhibitor) attenuated the TPA-induced expression of
IEGs in mouse ﬁbroblast [4]. Incubation of TSA or apicidin (a class
I HDAC inhibitor) 30 min before the addition of TPA to serum
starved HCT116 cells, prevented the induction of the FOSL1 and
PTGS2 genes (Fig. 3 and Fig. S1B and C). However, TSA or apicidin
alone did not induce these genes (Fig. S2). Dual cross-linking ChIP
assays were applied to determine whether the HDAC inhibitors
were affecting the recruitment of RNA polymerase II (RNAPII) to
the FOSL1 promoter. TPA induction of the FOSL1 gene resulted in
the accumulation of RNAPII at the promoter at 30 min, followed
by a decrease of RNAPII at 60 min (Fig. 4A). The initiation-
competent form of RNAPII (RNAPII S5ph) also increased at
30 min followed by a decline at 60 min. TSA or apicidin incubation
of HCT116 cells before TPA addition prevented the accumulation of
RNAPII at the FOSL1 promoter and the initiation of transcription as
indicated by the lack of elevated levels of RNAPII S5ph following
TPA induction (Fig. 4B and C).
The effect of the HDAC inhibitor on the loading of class I HDACs
on the FOSL1 gene was evaluated by dual cross-linking ChIP assays.
Fig. 5 shows that neither TSA nor apicidin treatment prevented the
recruitment of HDAC1, 2 and 3 to the gene body, but had minimal
impact on the accumulation of class I HDACs to the FOSL1 up-
stream promoter region.
To analyze the changes in histone acetylation levels at the up-
stream promoter region of FOSL1, dual cross-linking ChIP assays
were performed with antibodies against acetylated H3 (H3ac9/
14) and acetylated H4 (H4ac5/8/12/16) in TPA-induced cells pre-
treated with or without TSA or apicidin. A temporal increase in his-
tone H3 and H4 acetylation was observed in promoter region of
FOSL1 gene, with a greater level of H3 and H4 acetylation being at-
tained in the HDAC inhibitor treated cells (Fig. 6). These observa-
tions provide evidence that the increased KAT activity at the
FOSL1 upstream promoter region following TPA induction is not
prevented by inhibiting the activity of the HDACs residing at the
upstream promoter regions.
3.3. HDAC inhibitors do not perturb the nucleosome response
TPA induction of the RAS-MAPK pathway leads to the phosphor-
ylation of ERKs which in turn phosphorylate and activate MSK,
AB
Fig. 5. HDAC inhibitors restrict the accumulation of class I HDACs in gene body of FOSL1 gene. HCT116 cells were serum starved and incubated with TSA (250 nM) (A) or
apicidin (150 nM) (B) prior to the treatment with TPA for different time points as indicated. Dual cross-linked cells were processed for ChIP assays with HDAC1, HDAC2 and
HDAC3 antibodies and were analyzed by real time PCR at promoter and gene body (exons 1 and 4) of FOSL1 gene. Enrichment values, the average of three independent
experiments, are expressed as relative to time 0 values, and error bars indicate standard deviation.
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sponse) at the regulatory regions of IEGs [4]. As the nucleosome re-
sponse is required for the induction of CDKN1A gene, we
determined whether HDAC inhibitors affected the nucleosome re-
sponse pathway. As ERK activation is a key step in the pathway, we
determined the levels of phosphorylated ERK in TPA and TSA/TPA
or apicidin/TPA treated serum starved HCT116 cells. Fig. 7A shows
that neither TSA nor apicidin affected the phosphorylation and
activation of ERK. MSK can be activated by p38 MAP kinase path-
way as well [2]; we therefore analyzed the activation and phos-
phorylation of p38 kinase in our experimental settings. As a
control, we treated HCT116 cells with UV to activate p38 kinase.
Fig. 7B shows that UV treatment resulted in the phosphorylation
of p38. In contrast, separately or in combination TPA and the HDAC
inhibitors (TSA or apicidin) did not activate the p38 kinase path-
way. Next we determined the phosphorylation of H3S10 along
the regulatory and coding region of FOSL1 gene by ChIP assay
and whether this phosphorylation event was altered by HDAC
inhibitors. Fig. 8A shows that TPA-induced H3 S10 phosphorylation
occurred at the FOSL1 upstream promoter region but not within
the gene body (exon 1 and exon 4). The TPA-induced H3 S10 phos-
phorylation and localization to the upstream promoter region was
not prevented by the HDAC inhibitors TSA and apicidin. TSA in-
duced phosphorylation of H3S28, but not of H3S10, has been re-ported in mouse epidermal JB6 cells [16]. In serum starved
HCT116 cells, neither of the HDAC inhibitors induced phosphoryla-
tion of H3S10 or H3S28. Further neither of the HDAC inhibitors
prevented TPA induction of H3S10 and S28 phosphorylation
(Fig. 8B).
Following phosphorylation of H3, a critical event in the induc-
tion of IEGs is the recruitment of 14-3-3e and 14-3-3f [17]. We
investigated whether HDAC inhibitors prevented the recruitment
of the 14-3-3 proteins to the upstream promoter region of the
FOSL1 gene following TPA induction. Following TPA induction,
the 14-3-3 proteins were recruited to the upstream promoter,
but not to the coding region of the FOSL1 gene (Fig. 8C). Neither
TSA nor apicidin prevented the recruitment of the 14-3-3 proteins
to the FOSL1 upstream promoter region, indicating that the phos-
pho mark (H3S10ph) was effectively ‘read’ by 14-3-3 proteins in
cells treated with HDAC inhibitors. Together these results show
that the HDAC inhibitors do not interfere with the nucleosome re-
sponse pathway.
4. Discussion
Dynamic histone acetylation plays a critical role in the expres-
sion of IEGs [5]. Further dynamic acetylation occurs indepen-
dently of MSK-catalyzed H3 phosphorylation [18]. The dynamic
AB
Fig. 6. Effect of TSA or apicidin on acetylation of histone H3 and H4 at the FOSL1
upstream promoter region. HCT116 cells were serum-starved and then incubated
with or without HDAC inhibitors, TSA (250 nM) (A) or apicidin (150 nM) (B) for
30 min before being stimulated with TPA (100 nM) for 0, 30 or 60 min. Cells were
double cross-linked, processed to mononucleosomes for ChIP assays with acety-
lated Histone-H3 and H4 antibodies and analyzed by real time PCR at the upstream
promoter region of FOSL1 gene. Enrichment values are relative to time 0 values and
are the average of three independent experiments. The error bars represent
standard deviation.
D.H. Khan, J.R. Davie / FEBS Letters 587 (2013) 1510–1517 1515acetylation is catalyzed by KATs (CBP/p300/PCAF) and TSA-sensi-
tive HDACs [5]. TPA-induction of the IEG genes results in an
increased acetylation of histones at the upstream promoter regions
of these genes [1,5]. For nucleosomes positioned at the FOSL1 up-
stream promoter region, HDAC inhibitors (TSA and apicidin which
are structurally unrelated) did not prevent but enhanced the TPA-
induced histone acetylation. However, the HDAC inhibitors pre-
vented initiation of FOSL1 transcription induced by TPA. Previous
reports have shown that HDAC inhibitors alter gene expression,
ranging from 10% to 40% of genes within the genome, with theA
B
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TPA (100 nM) 0 30 600 30 60
TSA (-) TSA (+)
TPA (100 nM) 0 30 600 30 60 UV (+)
Fig. 7. Effect of HDAC inhibitors on TPA induced activation of MAP kinase pathways. Seru
150 nM apicidin (right panel) for 30 min followed by TPA treatment (100 nM) for indic
phospho-ERK (A) and phospho-p38 (B) by phospho-ERK1/2 and phospho-p38 antibodies
were analyzed as a positive control for phospho-p38.responsive genes being either up- or down-regulated [19–21].
Thus FOSL1 is with the group of genes which are down-regulated
by HDAC inhibitors.
In this report, we demonstrate the transcription dependent
recruitment of HDAC1, 2 and 3 to the gene body of the FOSL1 gene
in HCT116 cells. Throughout the study, we applied a dual cross-
linking ChIP assay. We previously reported that the use of DSP be-
fore formaldehyde was more efﬁcient in monitoring HDACs along
genes than using formaldehyde alone or other cross-linker pairs
(such as EGS/formaldehyde) [15,22]. We have also observed the
transcription dependent recruitment of HDAC1 and 2 to the in-
duced (TPA or estradiol) trefoil factor 1 gene body in human breast
cancer cell line MCF7 (data not shown). Thus the transcription
dependent recruitment of class I HDACs in mammalian cells to
the coding region of transcribed genes appears to be by a similar
mechanism as that reported in yeast [10,23]. Although the recruit-
ment of HDACs to the FOSL1 upstream promoter region and gene
body are dependent on transcription, the mechanisms by which
these enzymes are recruited to these two gene regions are different
and can be distinguished with HDAC inhibitors. The mechanism of
HDAC recruitment to the gene body is thought to be via RNAPII
which is required to transfer HDAC to the coding region of the
gene. As the HDAC inhibitors prevent the initiation of transcription,
RNAPII is not present to do this task. For the upstream promoter re-
gion, the nucleosome response pathway results in nucleosome
remodeling of the FOSL1 upstream promoter, allowing the recruit-
ment of transcription factors which in turn recruit HDACs which
are in multiprotein complexes such as Sin3A. HDAC inhibitors do
not inhibit these events and thus HDAC recruitment to the up-
stream promoter region is not affected by the HDAC inhibitors.
The activation of MSK and the nucleosome response is required
for the HDAC inhibitor-induced expression of CDKN1A [13]. For
several IEGs, HDAC inhibitors attenuate the TPA-induced expres-
sion of IEGs [4]. Our results show that the HDAC inhibitor, TSA or
apicidin did not impact the signal transduction pathways resulting
in the activation and phosphorylation of p38 and ERK kinases or
the MSK catalyzed nucleosome response events, including H3S10
phosphorylation and 14-3-3 recruitment to the FOSL1 upstream
promoter region. The HDAC inhibitors prevented subsequent
events leading to the productive initiation of FOSL1 transcription.
Consistent with our results, others have shown that HDAC inhibi-
tors can attenuate transcriptional initiation by abrogating the
binding of RNAPII and basal transcription factors to promoter re-
gions [24,25]. These results demonstrate that inhibition of class I
HDACs and dynamic protein acetylation can either promote or hin-
der transcription and likely depends on promoter/upstream pro-
moter region context.0 30 60 min
phERK1/2
ERK1/2 
Apicidin (-) Apicidin (+)
0 30 60
0 30 60 min
Apicidin (-) Apicidin (+)
0 30 60 UV (+)
ph p38 
p38 
m starved HCT116 cells were pretreated or not with 250 nM TSA (left panel) or with
ated time points. Total cellular extracts (20 lg) were analyzed for the induction of
. Total ERK1/2 and p38 were used as loading controls and UV treated cellular lysates
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Fig. 8. TSA or apicidin does not alter the TPA-induced nucleosomal response or the recruitment of chromatin modiﬁers to the regulatory region of FOSL1 gene. (A) HCT116
cells were cultured in serum-depleted conditions and were treated or not with 250 nM TSA (left panel) or with 150 nM apicidin (right panel) for 30 min prior to 100 nM of
TPA stimulation for 0, 30 or 60 min. Cells were dual cross-linked, processed to mononucleosomes and ChIP assays were performed with anti-H3S10ph antibody and analyzed
by real time PCR at the promoter and coding region of FOSL1 gene. Enrichment values are relative to time 0 values and are the average of three independent experiments. The
error bars represent standard deviation. (B) Serum starved HCT116 cells were treated or not with TSA (250 nM) (left panel) or with apicidin (150 nM) (right panel) for 30 min
before the stimulation with TPA (100 nM) for 0, 30 or 60 min. Acid-soluble nuclear histones (5 lg) were resolved on a 15%-SDS–PAGE and immunoblotting were done with
anti-H3S10ph, anti-H3S28ph and anti-total H3 (loading control) antibodies. (C) ChIP assays were done with or without TSA (left panel) or apicidin (right panel) pretreatment
followed by TPA induced conditions with14-3-3 e and 14-3-3 f antibodies as described in A.
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